Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Company Country Ticker View
RootLoc Co., Ltd. Logo
Develops and sells orthopedic solutions like artificial joints and spinal implants globally.
South Korea 253610
RUA LIFE SCIENCES PLC Logo
Develops and licenses implantable polymer tech and provides contract manufacturing services.
United Kingdom RUA
S2Medical AB Logo
Develops advanced wound healing and infection control solutions for burns and chronic wounds.
Sweden S2M
Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France ALSAF
Safilo Group Logo
Designs, manufactures, and distributes sunglasses, optical frames, and sports eyewear globally.
Italy SFL
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany 1SXP
Scope Fluidics S.A. Logo
Biotech venture builder creating microfluidic diagnostic systems for healthcare.
Poland SCP
Sedana Medical Logo
Develops inhaled sedation technology for mechanically ventilated patients in intensive care.
Sweden SEDANA

Talk to a Data Expert

Have a question? We'll get back to you promptly.